Preliminary studies reveal conolidine could inhibit specific ion channels, lowering neuronal excitability and limiting agony signals. This mechanism is particularly appropriate in neuropathic agony, where irregular signaling causes persistent soreness. On top of that, conolidine seems to affect G protein-coupled receptor (GPCR) pathways integral to soreness perception. Computational d... https://henryg582inu1.wikifordummies.com/user